Christel Larbouret
- Oncology top 5%
- Molecular Biology
- Radiology, Nuclear Medicine and Imaging top 5%
- Immunology top 10%
- Pulmonary and Respiratory Medicine
- Co-authors
- André PèlegrinBruno RobertD. AzriaThierry ChardèsNadège GaboritCaroline MolléviMarta JarlierWilhem Leconet
- Topics
- HER2/EGFR in Cancer Research (21 papers)Monoclonal and Polyclonal Antibodies Research (21 papers)Pancreatic and Hepatic Oncology Research (8 papers)
- Partner nations
- FranceSwitzerlandUnited Kingdom
In The Last Decade
Christel Larbouret
35 papers receiving 949 citations
Peers
Comparison fields: 5 of 73
- Oncology 652
- Molecular Biology 366
- Radiology, Nuclear Medicine and Imaging 356
- Immunology 224
- Pulmonary and Respiratory Medicine 128
Countries citing papers authored by Christel Larbouret
This map shows the geographic impact of Christel Larbouret's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christel Larbouret with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christel Larbouret more than expected).
Fields of papers citing papers by Christel Larbouret
This network shows the impact of papers produced by Christel Larbouret. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christel Larbouret. The network helps show where Christel Larbouret may publish in the future.
Co-authorship network of co-authors of Christel Larbouret
This figure shows the co-authorship network connecting the top 25 collaborators of Christel Larbouret. A scholar is included among the top collaborators of Christel Larbouret based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christel Larbouret. Christel Larbouret is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 6 | |
| 2 | 7 | |
| 3 | 3 | |
| 4 | 8 | |
| 5 | 13 | |
| 6 | 1 | |
| 7 | 13 | |
| 8 | 87 | |
| 9 | 44 | |
| 10 | 35 | |
| 11 | 0 | |
| 12 | 81 | |
| 13 | 35 | |
| 14 | 21 | |
| 15 | [Combination of anti-EGFR and anti-HER2 antibodies: hope in pancreatic cancer treatment]. | 1 |
| 16 | 11 | |
| 17 | 58 | |
| 18 | 8 | |
| 19 | [Radiotherapy and inhibitors of epidermal growth factor receptor: preclinical findings and preliminary clinical trials]. | 7 |
| 20 | 10 |
About Christel Larbouret
Christel Larbouret is a scholar working on Oncology, Radiology, Nuclear Medicine and Imaging and Immunology and Allergy, having authored 36 papers that have together received 971 indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (21 papers), Monoclonal and Polyclonal Antibodies Research (21 papers) and Pancreatic and Hepatic Oncology Research (8 papers). The work is most often cited by research in Oncology (652 citations), Radiology, Nuclear Medicine and Imaging (356 citations) and Immunology (224 citations). Christel Larbouret has collaborated with scholars based in France, Switzerland and United Kingdom. Frequent co-authors include André Pèlegrin, Bruno Robert, D. Azria, Thierry Chardès, Nadège Gaborit, Caroline Mollévi, Marta Jarlier, Wilhem Leconet, Jean‐Pierre Mach and Pierre Martineau. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.